Ensysce Biosciences, Inc.

ENSC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001716947

SEC filings (opens in a new tab)

In the last 90 days, Ensysce Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $261.1K in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Ensysce Biosciences, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of ENSC: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Q1 2025	Change
Holders	8	9	+1
Shares	140.8K	353.2K	+212.3K (+150.8%)
Value	$1.15M	$903.4K	−$242.5K (−21.2%)

New holders (2)

Institutions that held Ensysce Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to ENSC in Q1 2025
Institution	Shares	Value	% of portfolio
Murchinson Ltd.	140,000	$358.4K	0.06%
Sabby Management, LLC	46,954	$120.2K	0.50%

Sold out (1)

Institutions that held Ensysce Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of ENSC in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Morgan Stanley	52	$423